TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Jane Chao, Ph.D.
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

Ceribell obtained FDA 510(k) clearance for its ClarityⓇ algorithm, becoming the first AI-powered point-of-care EEG technology capable of detecting electrographic seizures across all patient ages, from pre-term neonates to adults.

Insights
AEM   positive

92% YTD performance, record Q3 earnings, reduced debt, 16 out of 17 analysts recommend buying with 18% upside potential


CBLL   positive

Achieved significant FDA regulatory milestone, expanded technological capabilities, addressed critical unmet medical need in neonatal seizure detection